621 Interim Analysis of a Phase II Study of Talimogene Laherparepvec (T-VEC) Followed by Combination T-VEC + Nivolumab in Non-Melanoma Skin Cancers and Refractory Cutaneous Lymphoma (NCI#10057) Ann W Silk,Gino K In, Nicole R Leboeuf, Diwakar Davar,Sunandana Chandra, George Ansstas,Melissa Burgess,Frederick Lansigan,Theresa Medina, Brad Haverkos,Stephen Williamson,John Hyngstrom, Howard L Kaufman,Anita Giobbie-Hurder, Harita Dharaneeswaran,Diane Del Valle,Kai Nie, Sinem Ozbey,Giorgio Ioannou, Igor De Souza Figueiredo, Ronaldo De Real, Bryan Villagomez, Elena Colicino,Seunghee Kim-Schulze, Kenneth Livak, Catherine J Wu, Helen Chen,Edgar Gonzalez-Kozlova,Sacha Gnjatic,Janice MehnertRegular and Young Investigator Award Abstracts（2024）引用 0|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
